Direct and indirect cellular effects of aspartame on the brain

European Journal of Clinical Nutrition

Volumn 62, Issue 4, 2008, Pages 451-462

  Humphries, P ^a,b   Pretorius, E ^a   Naude H ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF LIMPOPO   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ASPARAGINE; ASPARTAME; ASPARTIC ACID; CATECHOLAMINE; DOPAMINE; FORMALDEHYDE; FORMIC ACID; GLUTAMIC ACID; GLUTAMINE; METHANOL; NEUROTRANSMITTER; NORADRENALIN; PHENYLALANINE; PIPERAZINEDIONE; SWEETENING AGENT; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ADRENALIN BRAIN LEVEL; BEHAVIOR DISORDER; CATECHOLAMINE BRAIN LEVEL; CENTRAL NERVOUS SYSTEM; DOPAMINE BRAIN LEVEL; EMOTION; HEADACHE; HUMAN; INSOMNIA; LEARNING; MENTAL DISEASE; NEUROLOGIC DISEASE; NORADRENALIN BRAIN LEVEL; PATHOGENESIS; REVIEW; SEIZURE; BRAIN; DRUG EFFECT; METABOLISM;

ASPARTAME; ASPARTIC ACID; BRAIN; HUMANS; METHANOL; NEUROTRANSMITTER AGENTS; PHENYLALANINE; SWEETENING AGENTS;

EID: 47949129036     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602866     Document Type: Review

References (55)

1. Anonymous (1984). Evaluation of consumer complaints related to aspartame use. MMWR 33, 605-607.
2. Berger-Sweeńey J, Hohmann CF (1997). Behavioral consequences of abnormal cortical development: Insights into developmental disabilities. Behav Brain Res 86, 121-142.
3. Boutrel B, Franc B, Hen R, Hamon M, Adrien J (1999). Key role of 5-Ht1B receptors in the regulation of paradoxical sleep as evidenced in 5-HT1B knock-out mice. J Neurosci 19, 3204-3212.
4. Bowen J, Evangelista MA (2002). Brain cell damage from amino acid isolates: A primary concern from aspartame-based products and artificial sweetening agents. http://www.wnho.net/aspartame_brain_damage.htm.
5. Caballero B, Wurtman RJ (1988). Control of plasma phenylalanine levels. In: Wurtman RJ, Ritterwalker E (eds). Dietary phenylalanine and Brain Function. Birkhauser: Basal. pp 9-23.
6. Choi DW, Rothman SM (1990). The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 13, 171-182.
7. Chubakov AR, Gromova EA, Konovalov GV, Sarkisova EF, Chumasov EI (1986). The effects of serotonin on the morpho-functional development of rat cerebral neocortex in tissue culture. Brain Res 369, 285-297.
8. Chubakov AR, Tsyganova VG, Sarkisova EF (1993). The stimulating influence of the raphe nuclei on the morphofunctional development of the hippocampus during their combined cultivation. Neurosci Behav Physiol 23, 271-276.
9. Chugani DC (2004). Serotonin in autism and pediatric epilepsies. Mental Retard Dev Disabil Res Rev 10, 112-116.
10. Clarke J (2000). Aspartame concerns: An overview for health professionals. Additive Survivors Network: UK.
11. Cooper JR, Bloom FE, Roth RH (2003). The Biochemical Basis of Neuropharmacology, 8th edn. Oxford University Press: New York.
12. Coulombe RA, Sharma RS (1986). Neurobiochemical alterations induced by the artificial sweetener aspartame. (Nutrasweet). Toxicol Appl Pharmacol 83, 79-85.
13. Dare E, Fetissov S, Hokfelt T, Hall H, Ogren SO, Ceccatelli S (2003). Effects of prenatal exposure to methylmercury on dopamine-mediated locomotor activity and dopamine D2 receptor binding. Naunyn Schmiedebergs Arch Pharmacol 367, 500-508.
14. Diamorkd A, Briand L, Fossella J, Gehlbach L (2004). Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am J Psychiatry 161, 125-132.
15. Fernstorm JD, Fernstrom MH, Gillis MA (1983). Acute effects of aspartame on large neutral amino acid and mono-amines in rat brain. Life Sci 32, 1651-1658.
16. Fernstorm JD (1988). Effects of aspartame ingestion on large amino acids and monoamine neurotransmitters in the central nervous system. In: Wurtman RJ, Ritterwalker F. (eds). Dietary Phenylalanine And Brain Function. Birkhauser: Basal. pp 87-94.
17. Fernstrom JD (1994). Dietary amino acids and brain function. J Am Diet Ass 94 (1), 71-77.
18. Filer LJ, Stegink LD (1988). Effect of aspartame on plasma phenylalanine concentration in humans. In: Wurtman RJ, Ritterwalker E (eds). Dietary Phenylalanine and Brain Function. Birkhauser: Basal. pp 18-40.
19. Fountain SB, Hennes SK, Teyler TJ (1988). Aspartame exposure and in vitro hippocampal slice excitability and plasticity. Fundam Appl Toxicol 11, 221-228.
20. Ganong WF (1997). Review of Medical Physiology, 18th edn. Appleton and Lange: Stanford, Connecticut.
21. Gaspar P, Cases O, Maroteaux L (2003). The developmental role of serotonin: News from mouse molecular genetics. Nat Rev Neurosci 4, 1002-1012.
22. Hawkins RA, Mans AM, Biebuyck JF (1988). Regional transport and other neutral amino acids across the blood-brain barrier. In: Wurtman RJ, Ritter-Walker E (eds). Dietary Phenylalanine and Brain Function. Birkhauser: Basal. pp 60-67.
23. Herlenius E, Langercrantz H (2004). Development of neurotransmitter systems during critical periods. Exp Neurol 190, 8-21.
24. 3H]glutamate binding sites in rat brain synaptic membranes. Brain Res 520, 351-353.
25. Johns DR (1986). Migraine provoked by aspartame. Natl Eng J Med 315, 456.
26. Johnston MV, Silverstein FS (1998). Development of neurotransmitters. In: Polin RA, Fox WW (eds). Fetal and Neonatal Physiology. Saunders: Philadelphia. pp 2116-2117.
27. Kolb B, Whishaw IQ (2003). Fundamentals of Human Neuropsychology 5th edn Worth Publishers: New York.
28. Lauder JM (1990). Ontogeny of the serotonergic system in the rat: Serotonin as a developmental signal. Ann NY Acad Sci 600, 297-313.
29. Letinic K, Zoncu. R, Rakic P (2002). Origin of GABAergic neurons in the human neocortex. Nature 417, 645-649.
30. Lipton SA, Nakanishl N (1999). Shakespeare in love - with NMDA receptors? Nat Med 5, 270-271.
31. Maher TJ, Wartman RJ (1987). Possible neurologic effects of aspartame, a widely used food additive. Environ Health Perspect 75, 53-57.
32. McDonald JW, Johnston MV (1990). Physiological and pathophysiological roles of excitatory amino acids during central nervous system de-velopment. Brain Res Brain Res Rev 15, 41-70.
33. Mehl-Madrona L (2005). Autism an overview and theories on its causes http://www.healingarts.org/mehl-madrona/autism accessed:17 December 2005.
34. Noctor SC, Flint AC, Weissman TA, Dammerman RS, Kriegstein AR (2001). Neurons derived from radial glial cells establish radial units in neocortex. Nature 409, 714-720.
35. Noctor SC, Martinez-Cerdeno V, Ivic L, Kriegstein AR (2004). Cortical neurons arise in symmetric and asymmetric division zones and migrate through specific phases. Nat Neurosci 7, 136-144.
36. Olney JW (1975). Letter to the editor. N Engl J Med 292 (23).
37. Owens DF, Kriegstein AR (2002). Is there more to GABA than synaptic inhibition? Nat Rev Neurosci 3, 715-727.
38. Panksepp J (1998). Affective Neuroscience: The Foundations or Human and Animal Emotions. Oxford University Press: New York.
39. Qu Y, Vadivelu S, Choi L, Liu S, Lu A, Lewis B et al. (2003). Neurons derived from embryonic stem (ES) cells resemble normal neurons in their vulnerability to excitotoxic death. Exp Neurol 184, 326-336.
40. Sharma RP, Coulombe Jr RA (1987). Effects of repeated doses of aspartame on serotonin and its metabolite in various regions of the mouse brain. Food Chem Toxicol 25 (8), 565-568.
41. Stegink LD, Filer LJ, Baker CL (1988). Repeated ingestion of aspartame-sweetened beverage: Effect on plasma amino acid concentrations in normal adults. Metabolism 37 (3), 246-251.
42. Stegink LD, Filer LJ, Bell EF, Ziegler EE, Tephly TR (1989). Effect of repeated ingestion of aspartame-sweetened beverage on plasma amino acid, blood methanol, and blood formate concentrations. Metabolism 34 (4), 357-363.
43. Stone TW, Burton NR (1988). NMDA receptors and ligands in the vertebrate CNS. Prog Neurobiol 30, 333-368.
44. Sundstrom E, Kolare S, Souverbie F, Samuelsson EB, Pschera H, Lunell NO et al. (1993). Neurochemical differenti-ation of human bulbospinal monoaminergic neurons during e first trimester. Brain Res Dev Brain Res 75, 1-12.
45. Sundstrom. E (1996). First trimester development of the human nigros-triatal dopamine system. Exp Neurol 139, 227-237.
46. Trocho C, Pardo R, Rafecas I, Virgili J, Remesar X, Fernandez-Lopez JA et al. (1998). Formaldehyde derived from dietary aspartame binds to tissue components in vivo. Life Sci 63, 337-349.
47. Turlejski K (1996). Evolutionary ancient roles of serotonin: Long-lasting regulation of activity and development. Acta Neurobiol Exp 56, 619-636.
48. Wang F, Lidow MS (1997). Alpha 2A-adrenergic receptors are expressed by diverse cell types in the fetal primate cerebral wall. J Comp Neurol 378, 493-507.
49. Watkins JC (1984). Excitatory amino acids and central synaptic transmission. Trends Pharmacol 5, 373-376.
50. Williams GV, Goldman-Rakic PS (1995). Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376, 572-575.
51. Whitaker-Azmitia PM (1991). Role of serotonin and other neurotrans-mitter receptors in brain development: Basis for devel opmental pharmacology. Pharmacol Rev 43, 553-561.
52. Whitaker-Azmitia PM, Druse M, Walker P, Lauder JM (1996). Serotonin as a developmental signal. Behav Brain Res 73, 19-29.
53. Whitaker-Azmitia PM (2001). Serotonin and brain development: Role in human developmental diseases. Brain Res Bull 56 (5), 479-485.
54. Young SN (1988). Facts and myths related to the regulation of phenylalanine and other amino 'Dietary phenylalanine and brain function'. In: Wurtman RJ, Ritterwalker E (eds). Use and Aids. Birkhauser: Basal. pp 341-347.
55. Zhou QY, Palmiter. RD (1995). Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83, 1197-1209.